Full-Time

Director – Internal Controls and Financial SOX Compliance

Posted on 1/10/2025

Twist Bioscience

Twist Bioscience

1,001-5,000 employees

Produces synthetic DNA for biotechnology applications

Compensation Overview

$198k - $270kAnnually

+ Bonus + Equity

Senior, Expert

San Bruno, CA, USA

California-based role; compensation may vary in other locations.

Category
Financial Accounting
Financial Controller
Accounting
Requirements
  • Bachelor’s degree in Accounting, Business Administration, Computer Science, Engineering, Information Systems, or related discipline
  • Hands-on SOX experience, including successful remediation of compliance deficiencies and material weaknesses with similar size public companies
  • 10+ years of relevant work experience, with a combination of public accounting experience focused on SOX compliance and/or corporate SOX experience in a similar-size public company, with a minimum of 5 years of experience in technology or support of technology
  • Certified Public Accountant (CPA) or equivalent accounting certification preferred
  • Deep understanding of SOX regulations and internal control frameworks, including the Sarbanes-Oxley Act, the 2013 COSO framework, NIST, COBIT, SOC, DCAM, and SEC guidance for management's assessment of internal controls over financial reporting
  • Critical thinking, analytical, leadership, planning, project management, and organizational skills
  • Proven ability to build relationships and influence and motivate teams to ensure that the work activities are established, understood, supported, and completed in a timely manner
  • Proficient in Microsoft Office suite applications
Responsibilities
  • Act as a hands-on leader and SOX compliance subject matter expert who works with cross-functional process owners, IT, and accounting to help achieve ongoing design, review control documentation, and remediation of controls for Sarbanes-Oxley compliance
  • Lead and manage a team of SOX compliance professionals, including analysts, third-party service providers, and subject matter experts
  • Provide strategic thinking, thought leadership, and guidance on identifying gaps in key controls and design a proactive risk assessment
  • Plan and manage direct activities of the team to align governance programs with the organization’s objectives and execute roadmaps
  • Provide guidance, assessment, and oversight on the governance of Change Management and System Access Controls and provide recommendations on the next level of maturity strategy/roadmap and standards
  • Work with Internal Audit on the completion of a comprehensive risk assessment, documentation, risk mitigation guidance, and related reporting for key enterprise initiatives, across various technologies, platforms, and environments including those relative to business technology integrations
  • Partner with control owners to perform management assessment of risk over internal controls and identify opportunities for control improvement and design of new controls
  • Collaborate with Internal Audit on the assessment of internal controls to finalize and track remediation of identified control gaps
  • Act as a change agent, influencer, cross-functional leader, and collaborator to drive and facilitate ongoing SOX and compliance training programs for IT process and control owners
  • Maintain and enhance SOX controls documentation to ensure they reflect the current environment and comply with SOX requirements, including testing documentation and systems diagrams
  • Proactively participate and guide the team in planning, prioritizing, and delivering system enhancements and maintain documentation concerning planning, status, testing results, and other reporting needs
  • Work with internal audit to conduct risk-based audits to determine soundness, adequacy, and application of key and controls, including identifying control weaknesses, exceptions, and deficiencies in operations
  • Monitor business changes and update SOX controls accordingly to maintain compliance with evolving regulations
  • Implement process improvements to streamline SOX compliance activities and enhance efficiency
  • Partner with IT control owners on implementation of new systems and design of new controls
  • Conduct and/or manage special projects and ad hoc requests to support the senior leadership team and other duties as assigned.
Desired Qualifications
  • Certified Public Accountant (CPA) or equivalent accounting certification preferred

Twist Bioscience focuses on synthesizing synthetic DNA for applications in biotechnology, pharmaceuticals, and research. Their proprietary platform allows for the quick and accurate production of DNA sequences, providing clients with instant feedback on their projects. The company stands out by offering high-quality DNA products at competitive prices, catering to a diverse range of clients. Twist Bioscience aims to be a leading supplier in the synthetic biology sector, supporting the growing demand for personalized medicine.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

South San Francisco, California

Founded

2013

Simplify Jobs

Simplify's Take

What believers are saying

  • Collaboration with Absci enhances capabilities in AI-driven antibody discovery.
  • Partnership with MedGenome positions them as a key player in precision medicine.
  • Launch of CHO Express Antibodies expands their market share in antibody production.

What critics are saying

  • Increased competition from companies like Ginkgo Bioworks could impact market share.
  • Dependency on AI technologies may pose risks if not managed properly.
  • New CIO appointment may lead to transitional challenges in IT strategy and operations.

What makes Twist Bioscience unique

  • Twist Bioscience uses a unique silicon-based DNA synthesis platform for precision and scale.
  • They offer high-quality DNA sequences at competitive prices, attracting diverse clients.
  • Their proprietary platform provides instant feedback on DNA sequence synthesis feasibility.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Disability Insurance

Life Insurance

401(k) Retirement Plan

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

-1%
TipRanks
Nov 26th, 2024
Twist Bioscience named a Best Idea for 2025 at TD Cowen

Twist Bioscience named a Best Idea for 2025 at TD Cowen.

SynBioBeta
Oct 31st, 2024
Absci and Twist Bioscience Team Up to Redefine Antibody Discovery with AI

Absci, a pioneer in generative AI-driven drug discovery, and Twist Bioscience, a leader in high-quality synthetic DNA production through its silicon platform, have announced an innovative collaboration to create a novel therapeutic antibody using generative AI.

Investing.com
Oct 25th, 2024
Twist Bioscience president sells $97,428 in stock

In other recent news, Twist Bioscience has secured a $15 million capital boost from a new financial agreement with XOMA Royalty Corporation.

Bakersfield.com
Oct 22nd, 2024
Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced it has entered into a royalty purchase agreement with XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator.

Stock Titan
Oct 15th, 2024
Twist Bioscience Appoints Mike Fero, Ph.D., as Chief Information Officer

SOUTH SAN FRANCISCO, Calif.-(BUSINESS WIRE)- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the appointment of Mike Fero, Ph.D., as chief information officer.

INACTIVE